Identifying coronary artery disease in men with type 2 diabetes: osteoprotegerin, pulse wave velocity, and other biomarkers of cardiovascular risk.
Ashley, David T
O'Sullivan, Eoin P
Corley, Brian T
Thompson, Christopher J
O'Gorman, Donal J
AffiliationDepartment of Diabetes and Endocrinology, Royal College of Surgeons in Ireland, Medical School, Beaumont Hospital, Dublin, Ireland. email@example.com
MetadataShow full item record
CitationJ Hypertens. 2011 Dec;29(12):2469-75.
JournalJournal of hypertension
AbstractOBJECTIVES: In patients with type 2 diabetes, high serum levels of osteoprotegerin (OPG) have been associated with a greater risk of cardiovascular events. However, it remains unclear how well OPG performs when compared with traditional biomarkers of cardiovascular risk such as high-sensitivity C-reactive protein (hsCRP). Furthermore, OPG levels are also high in the presence of diabetes-related microvascular disease, and it is unclear whether OPG can distinguish microvascular disease from large-vessel atherosclerosis. The first aim of this study was to compare OPG levels against other biomarkers of cardiovascular risk in the identification of patients with documented multivessel coronary artery disease (CAD). The second aim was to compare OPG levels in patients with microvascular complications (microalbuminuria) against those with established CAD. METHODS: Three groups of male patients with type 2 diabetes were recruited: patients without microvascular complications or large-vessel atherosclerosis (n = 24), patients with microalbuminuria only (n = 23), and patients with microalbuminuria and documented multivessel CAD (n = 25). OPG, hsCRP, interleukin 6, urate, and pulse wave velocity were measured. RESULTS: Serum OPG levels were significantly higher in patients with a combination of microalbuminuria and CAD than in those with microalbuminuria alone. There were no significant differences in any of the other biomarkers between the groups. CONCLUSION: OPG was found to be superior to the other biomarkers studied in identifying patients with documented CAD. The presence of CAD was a greater determinant of serum OPG levels than microalbuminuria in our population. These findings support the use of OPG as a biomarker of cardiovascular risk.
- The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
- Authors: Anand DV, Lahiri A, Lim E, Hopkins D, Corder R
- Issue date: 2006 May 2
- Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.
- Authors: Tousoulis D, Siasos G, Maniatis K, Oikonomou E, Kioufis S, Zaromitidou M, Paraskevopoulos T, Michalea S, Kollia C, Miliou A, Kokkou E, Papavassiliou AG, Stefanadis C
- Issue date: 2013 Sep 1
- Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension.
- Authors: Palazzuoli A, Ascione R, Gallotta M, Calabrò A, Gonnelli S, Quatrini I, Campagna MS, Franci B, Nuti R
- Issue date: 2009 Nov 12
- Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes.
- Authors: Blázquez-Medela AM, García-Ortiz L, Gómez-Marcos MA, Recio-Rodriguez JI, Sánchez-Rodríguez A, López-Novoa JM, Martínez-Salgado C
- Issue date: 2012 May
- Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria.
- Authors: Reinhard H, Nybo M, Hansen PR, Wiinberg N, Kjær A, Petersen CL, Winther K, Parving HH, Rasmussen LM, Rossing P, Jacobsen PK
- Issue date: 2011 Jul 29